[NCHHSTP] Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Targeting Consumers
Extension without change of a currently approved collection
No
Regular
08/31/2023
Requested
Previously Approved
36 Months From Approved
08/31/2023
108,975
36,325
11,253
3,751
0
0
CDC launched Act Against AIDS (AAA) in 2009 as a 5-year, multifaceted communication campaign to reduce HIV incidence in the US. The purpose is to evaluate the effectiveness of the AAA campaign messages on desired outcomes, and to determine mediating & moderating effects of participant characteristics on HIV-related outcomes. Changes to be examined include: attitudes, beliefs, & knowledge about HIV; receptivity to AAA campaign messages; perceived credibility; perceived risks of HIV & importance of HIV prevention & testing; intentions related to HIV prevention & testing; and HIV-related behaviors. Surveys will be used to evaluate the effectiveness of AAA campaign messages during the campaign development phase and to examine the associations between those groups who report exposure & those reporting no exposure to various AAA messages. Participants will self-administer. This is an Extension of the Generic ICR that requests approval for an additional three years.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Att 8_PIA - No PII_2023.pdf
Att 7_Sensitive Questions.docx